NCT03704714: An ongoing trial by Northwestern University
This trial is ongoing. It must report results 4 days, 2 hours ago.
Full data
| Full entry on ClinicalTrials.gov | NCT03704714 |
|---|---|
| Title | Phase I/II Study to Evaluate the Safety and Efficacy of Nivolumab in Combination With R-CHOP in a Cohort of Patients With DLBCL/tFL/ High Grade B-NHL |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Nov. 20, 2018 |
| Completion date | Dec. 11, 2024 |
| Required reporting date | Dec. 11, 2025, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |